COVID Omicron: Too Early To Bet On A Rebound
Tickmill | Nov 29, 2021 08:38AM ET
On Monday, risk assets rebounded as reports over the weekend suggest that the bout of COVID hysteria on Friday could be an overreaction. Air travel halts have eased off over the weekend, while the WHO and South African researchers alleviated concerns with a statement that there are no pieces of evidence yet that the new COVID strain is more dangerous than dominating delta strain.
In this regard, the flow of negative news for the market, mainly related to new shocks in air transportation, is likely to slow down this week. Nevertheless, it is too early to say that correction is over - the lack of reliable data on the new strain should keep risk appetite largely subdued this week. According to the WHO, it will take several days to several weeks to understand whether a new variant of the virus is more aggressive and resistant to vaccines.
Concerning contagiousness, there is a reason for concern. South Africa saw a jump in reported cases of COVID in November before the news about the new strain hit the wires, which may be indirect evidence that the virus is more easily transmitted from person to person.
New updates on COVID, essential for the markets, will appear today - Britain will gather ministers of the Ministry of Health of the G7 countries to discuss options for response. In the evening, Biden will deliver a message. It should help to understand the readiness of the governments to take painful preventive decisions.
Thanks to the relief rally, a barometer of expectations for a tightening of the Fed's policy - long-term rates, halved declines on Monday. The yield on the United States 10-Year Treasury bonds rose 7 basis points to 1.54%, and the yield on United States 2-Year bonds also gained about the same amount. European markets rose cautiously – gains do not exceed 1%, and it's difficult to expect more.
Buyers' optimism in the oil market is now mainly based on rumors that OPEC will postpone the planned hike in production by 400K barrels in January. Still, if more countries opt to close borders, we cannot avoid a more significant drop if we see more reports.
Noteworthy reports this week are Germany's CPI in November (released today), ADP, and NFP US November report. In addition, the first two days of the week are full of speeches from Fed representatives Powell, Williams).
Markets are unlikely to react in cold blood to the comments that may touch on the topic of the new strain, as this will call into question the Fed's intentions to accelerate the phasing out of stimulus measures (QE). In general, one way or another, trading in the market this week should be reduced to reactions to news associated with COVID and should be characterized by more or less homogeneous risk-off/risk-on.
Get The News You Want
There is a risk of further decline in EUR/USD since Europe's bullish rate expectations are under pressure due to the recent trend to reinstate lockdowns. Besides, it is geographically closer to South Africa and, if the new virus is indeed infectious, a new wave may hit it earlier than the United States. Considering the dollar index (DXY), the pullback after strong growth sets the stage for a further rally towards 97.70, where the next key resistance may reside.
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.